Phantomics
About Phantomics
Phantomics is a healthcare AI company dedicated to overcoming cardiovascular diseases through accurate and reliable AI-driven diagnostic imaging technologies. Founded in 2019, the company integrates advanced artificial intelligence with medical imaging to develop next-generation solutions capable of detecting disease biomarkers and predicting prognoses. Their mission is to revolutionize early detection and prevention of cardiovascular and other critical diseases, aiming to make state-of-the-art medical technologies accessible to every hospital worldwide.
The company’s flagship solution, Myomics, utilizes AI-powered, non-invasive cardiac MRI and CT analysis to provide rapid and accurate diagnostic results for myocardial diseases such as heart failure, myocarditis, and amyloidosis. Myomics is actively used in over 20 major general and secondary hospitals in South Korea, as well as in 19 international medical institutions, and has received regulatory approvals including U.S. FDA clearance. Phantomics is also expanding its research and development to include non-invasive diagnostic solutions for liver and muscle wasting diseases.
Phantomics aims to lower the barriers of cardiac MRI and CT examinations by providing standardized AI solutions, thereby creating a beneficial ecosystem for both medical professionals and patients. The company’s technology provides quantitative and precise disease diagnosis and prognosis prediction by comprehensively analyzing medical images and biomarkers, enabling physicians to make accurate decisions.
Focus Areas
Business Intelligence
| Key Investors | Devsisters Ventures, Bigbang Angels, COMEUP STARS, DAYLI Partners, Tech Incubator Program for Startup |
| Partnerships | GE HealthCare Korea, Philmedis Clinic, Yonsei University Severance Hospital, Siemens Healthineers Korea, Yujeong Meditech |
| Technology | AI-powered diagnostic platforms, advanced AI algorithms, image biomarker technology, cloud-native solutions, automated contour detection, quantitative analysis (ejection fraction, stroke volume, mass, wall motion, strain, T1/T2 mapping, tissue characterization, LGE quantification, flow assessment) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Phantomics' solutions, like Myomics and Angiomics, offer physicians a 'virtual fellow' for faster, more accurate, and standardized cardiac imaging analysis. This can significantly reduce the burden of manual interpretation, improve diagnostic confidence, and enable earlier intervention for critical cardiovascular conditions. The non-invasive nature of their image biomarker technology provides a safer alternative to traditional invasive procedures like myocardial tissue biopsies. Physicians can leverage these tools to streamline workflows, enhance diagnostic capabilities even without immediate access to highly specialized experts, and ultimately improve patient outcomes through precise and timely diagnoses.
Phantomics' solutions are designed for seamless integration into existing healthcare IT infrastructure, including hospital information systems, and are accessible via web and mobile platforms. They are actively pursuing partnerships with medical imaging platform vendors and have a strategic MOU with GE HealthCare Korea to co-develop new product features and improve image quality and scan protocols, indicating strong potential for integration with various imaging equipment and PACS systems.
What the Web Says
Phantomics appears to be a company with a focus on medical imaging and AI, specifically in the cardiovascular space. While direct product reviews on major platforms like G2, Capterra, or even dedicated healthcare IT review sites are scarce, the company's LinkedIn presence and academic collaborations suggest a strong scientific foundation. Employer reviews are also not readily available on Glassdoor or Reddit, indicating it might be a smaller or less publicly reviewed entity.
Overall: MixedStrengths
- Focus on cutting-edge AI in cardiovascular imaging.
- Potential for significant impact in medical diagnostics.
- Likely strong scientific and technical expertise within the company.
- Collaborations with academic institutions (implied by research focus).
- Addresses a critical need in healthcare for improved diagnostics.
- Innovative approach to medical data analysis.
Limitations
- Lack of readily available product reviews on major platforms (G2, Capterra).
- Limited public information regarding customer satisfaction.
- Absence of employer reviews on Glassdoor or Reddit.
- Might be a relatively new or niche company, leading to less public discourse.
- Potential for long sales cycles typical in healthcare IT.
- High regulatory hurdles inherent in medical device/software development.
Based on reviews from: G2 (no direct reviews found), Glassdoor (no direct reviews found), Capterra (no direct reviews found), Healthcare IT reviewers (no specific reviews found, general industry knowledge applied), Reddit (no direct reviews found), LinkedIn (company profile, general industry presence)
Last updated: 2026-07-18
Videos
News, demos, and interviews about Phantomics.
Videos load interactively. If none appear, search YouTube for Phantomics →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]